Literature DB >> 25432722

Atypical parkinsonism: diagnosis and treatment.

Maria Stamelou1, Kailash P Bhatia2.   

Abstract

Atypical parkinsonism comprises typically progressive supranuclear palsy, corticobasal degeneration, and mutilple system atrophy, which are distinct pathologic entities; despite ongoing research, their cause and pathophysiology are still unknown, and there are no biomarkers or effective treatments available. The expanding phenotypic spectrum of these disorders as well as the expanding pathologic spectrum of their classic phenotypes makes the early differential diagnosis challenging for the clinician. Here, clinical features and investigations that may help to diagnose these conditions and the existing limited treatment options are discussed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atypical parkinsonism; Corticobasal degeneration; Diagnosis; Multiple system atrophy; Progressive supranuclear palsy

Mesh:

Year:  2015        PMID: 25432722     DOI: 10.1016/j.ncl.2014.09.012

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  11 in total

1.  Cardiac 123I-MIBG scintigraphy: A window into the brain in Parkinsonism?

Authors:  Lamotte Guillaume; Agostini Denis
Journal:  J Nucl Cardiol       Date:  2015-12-07       Impact factor: 5.952

Review 2.  Imaging pathological tau in atypical parkinsonian disorders.

Authors:  Sarah Coakeley; Antonio P Strafella
Journal:  Curr Opin Neurol       Date:  2015-08       Impact factor: 5.710

3.  Superficial siderosis misdiagnosed as idiopathic bilateral neurosensorial deafness.

Authors:  H A González-Usigli; Teresa Perez-Torres; Michel Saenz-Farret; Paloma Rivero-Moragrega
Journal:  BMJ Case Rep       Date:  2018-07-11

Review 4.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

5.  Utility of 18F FDG-PET in Parkinsonism in an African population.

Authors:  Ferzana Hassan Amod; Ahmed Iqbal Bhigjee; Nozipho Nyakale
Journal:  eNeurologicalSci       Date:  2022-03-31

Review 6.  Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature.

Authors:  Rikitha Menezes; Alexander Pantelyat; Izlem Izbudak; Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

Review 7.  Imaging tau pathology in Parkinsonisms.

Authors:  Sarah Coakeley; Antonio P Strafella
Journal:  NPJ Parkinsons Dis       Date:  2017-06-29

8.  Elevated serum growth differentiation factor 15 in multiple system atrophy patients: A case control study.

Authors:  Tao Yue; Hui Lu; Xiao-Mei Yao; Xia Du; Ling-Ling Wang; Dan-Dan Guo; Yi-Ming Liu
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

Review 9.  The role of diffusion magnetic resonance imaging in Parkinson's disease and in the differential diagnosis with atypical parkinsonism.

Authors:  Romulo Varella de Oliveira; João Santos Pereira
Journal:  Radiol Bras       Date:  2017 Jul-Aug

Review 10.  Neuropsychiatric disturbances in atypical parkinsonian disorders.

Authors:  Daniele Belvisi; Isabella Berardelli; Antonio Suppa; Andrea Fabbrini; Massimo Pasquini; Maurizio Pompili; Giovanni Fabbrini
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.